Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001649094-25-000028
Filing Date
2025-02-25
Accepted
2025-02-25 16:11:25
Documents
127
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K pcvx-20241231.htm   iXBRL 10-K 2351562
2 EX-10.22 exhibit1022.htm EX-10.22 544224
3 EX-19.1 exhibit191-vaxcytexinsider.htm EX-19.1 77493
4 EX-23.1 exhibit231.htm EX-23.1 2664
5 EX-31.1 exhibit311.htm EX-31.1 10652
6 EX-31.2 exhibit312.htm EX-31.2 11226
7 EX-32.1 exhibit321.htm EX-32.1 6371
13 image_1.jpg GRAPHIC 162421
14 pcvx-20241231_g1.jpg GRAPHIC 166663
15 pcvx-20241231_g10.jpg GRAPHIC 30358
16 pcvx-20241231_g11.jpg GRAPHIC 78551
17 pcvx-20241231_g12.jpg GRAPHIC 156484
18 pcvx-20241231_g13.jpg GRAPHIC 205172
19 pcvx-20241231_g14.jpg GRAPHIC 157975
20 pcvx-20241231_g15.jpg GRAPHIC 172806
21 pcvx-20241231_g16.jpg GRAPHIC 155878
22 pcvx-20241231_g17.jpg GRAPHIC 266028
23 pcvx-20241231_g18.jpg GRAPHIC 190867
24 pcvx-20241231_g19.jpg GRAPHIC 30051
25 pcvx-20241231_g2.jpg GRAPHIC 43257
26 pcvx-20241231_g20.jpg GRAPHIC 33995
27 pcvx-20241231_g21.jpg GRAPHIC 268313
28 pcvx-20241231_g22.jpg GRAPHIC 79696
29 pcvx-20241231_g23.jpg GRAPHIC 38225
30 pcvx-20241231_g24.jpg GRAPHIC 59853
31 pcvx-20241231_g25.jpg GRAPHIC 30974
32 pcvx-20241231_g26.jpg GRAPHIC 30695
33 pcvx-20241231_g27.jpg GRAPHIC 147846
34 pcvx-20241231_g28.jpg GRAPHIC 68748
35 pcvx-20241231_g29.jpg GRAPHIC 32371
36 pcvx-20241231_g3.jpg GRAPHIC 139743
37 pcvx-20241231_g30.jpg GRAPHIC 110249
38 pcvx-20241231_g31.jpg GRAPHIC 156796
39 pcvx-20241231_g32.jpg GRAPHIC 44513
40 pcvx-20241231_g33.jpg GRAPHIC 32414
41 pcvx-20241231_g34.jpg GRAPHIC 39115
42 pcvx-20241231_g35.jpg GRAPHIC 147161
43 pcvx-20241231_g36.jpg GRAPHIC 136532
44 pcvx-20241231_g37.jpg GRAPHIC 59463
45 pcvx-20241231_g38.jpg GRAPHIC 40492
46 pcvx-20241231_g4.jpg GRAPHIC 37271
47 pcvx-20241231_g5.jpg GRAPHIC 31796
48 pcvx-20241231_g6.jpg GRAPHIC 15217
49 pcvx-20241231_g7.jpg GRAPHIC 15460
50 pcvx-20241231_g8.jpg GRAPHIC 256836
51 pcvx-20241231_g9.jpg GRAPHIC 48287
  Complete submission text file 0001649094-25-000028.txt   19320088

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20241231.xsd EX-101.SCH 65020
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcvx-20241231_cal.xml EX-101.CAL 93312
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcvx-20241231_def.xml EX-101.DEF 273071
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20241231_lab.xml EX-101.LAB 786428
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20241231_pre.xml EX-101.PRE 533689
130 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20241231_htm.xml XML 1223076
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39323 | Film No.: 25663229
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)